Publications

Editorial Comment Ppublish

PubMed: 39964706 DOI: 10.1182/bloodadvances.2024015400

The transplant debate: defining innovation for sickle cell.

Blood Adv 9(4):933-934

Authors: Cécile Karsenty, Titilope Fasipe, Alexander I Ngwube

Affiliations

  • Division Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Sickle Cell and Thalassemia Program, Cancer and Hematology Center, Texas Children's Hospital, Houston, TX.
  • Cell Therapy and Bone Marrow Transplant Program, Cancer and Hematology Center, Texas Children's Hospital, Houston, TX.

MeSH

Cells, Transplants, Hematologic Diseases